Fall Risk Assessment With an Innovative Device for Quantifying Gait and Static Balance in Geriatric Consultation

NCT ID: NCT06535477

Last Updated: 2025-09-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

169 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-28

Study Completion Date

2027-01-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this monocentric, non-randomized, prospective study was to evaluate the predictive capacity of a balance score based on spatio-temporal parameters of postural balance.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patient recruitment will take place at one center. The inclusion period is 6 months and the participation period for each subject will be 12 months with 3 visits: initial visit, telephone visit at 6 months, M12 consultation visit, and the end-of-study visit.

Consent will be obtained prior to participation, and the following data will be collected during the visits: Demographic data (age, gender), weight, height, geriatric assessment. Current treatment (molecules, date of introduction, dosage). Biological data: Albumin, Pre-Albumin, Creatinine, Hemoglobin, Vitamin D.

Static balance parameters via AbilyCare (static balance test, inspired by the Romberg test, on a balance platform, 30 seconds eyes open then 30 seconds eyes closed).

The total duration of the research is 18 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Risk of Falling in the Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Assessing frailty in elderly patients using Fried Frailty and "Short Emergency Geriatric Assessment" scales combined with measurement - via the AbilyCare device - of the two markers of balance and gait
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fall risk assessment

Assessing frailty in elderly patients using Fried Frailty and "Short Emergency Geriatric Assessment" scales combined with measurement - via the AbilyCare device - of the two markers of balance and gait

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject with a "Autonomie, Gérontologie, Groupes IsoRessources" (GIR) score ≥ 4 at the time of consultation
* Subject presenting an The mini mental status exam (MMSE) score ≥ 18 at the time of consultation
* Subject agreeing in writing (consent), after having been informed and given a reasonable period of reflection, to participate in the study
* Subject affiliated to a social security scheme.

Exclusion Criteria

* Subjects with a major or systemic pathology likely to significantly impair motor skills (inability to perform a 10m walking test without assistance, inability to perform a balance test on a scale without assistance (30 seconds eyes open / 30 seconds eyes closed),
* Subject with an advanced neurodegenerative pathology (Alzheimer, Parkinson, etc.) deemed incompatible with the objectives of the study by the investigator,
* Subjects with a history of disabling cerebrovascular accident,
* Subject with an active disabling cancer,
* Subjects with severe psychiatric disorders affecting their ability to perform walking and balance tests and/or answer study questionnaires,
* Subjects benefiting from a technical aid for walking and balance such as a cane, walker, etc. (only orthopedic insoles and shoes are accepted); subjects with a total hip or knee prosthesis are included,
* Subject having been hospitalized for a fall in the last 3 months prior to inclusion,
* Subject unable to understand the purpose of the research, answer questions and give his/her decision to participate in the study,
* Subject already included in another research study involving the human body,
* Subject not affiliated to a social security scheme or not benefiting from such a scheme.
* Person deprived of liberty by judicial or administrative decision
* Person of full age subject to a legal protection measure (guardianship, curatorship, safeguard of justice) or unable to express consent.
Minimum Eligible Age

65 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gérond'if

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sylvie Pariel, MD

Role: STUDY_CHAIR

Ambulatory Care Department, Charles Foix Hospital

Lina MICHELET, MD

Role: STUDY_DIRECTOR

Abilycare

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ambulatory Care Department, Charles Foix Hospital

Ivry-sur-Seine, IIe-de-France, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Isabelle DUFOUR

Role: CONTACT

+ 33 (0) 185781011

Albatoul ZAKARIA, Ph.D

Role: CONTACT

+33 (0) 185781010

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sylvie Pariel, MD

Role: primary

+33 (0) 149594385

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A00055-42

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Postural Control in the Elderly
NCT00059501 COMPLETED